Extending multipoint pacing CRT battery longevity by swapping left ventricular pulse configurations.
Juan José García Guerrero1, Joaquín Fernández de la Concha Castañeda2, Antonio Chacón Piñero2
1Hospital Universitario de Badajoz, Av. de Elvas, s/n, 06080, Badajoz, Spain. juanjose.gargue@gmail.com.
Summary
Optimizing cardiac resynchronization therapy (CRT) with MultiPoint™ pacing (MPP) by configuring left ventricular (LV) pacing sites significantly reduces battery drain. This strategy leverages the LVCap™ Confirm algorithm to improve device longevity.
Area of Science:
- Cardiology
- Medical Devices
- Biomedical Engineering
Background:
- Cardiac resynchronization therapy (CRT) improves outcomes in heart failure patients.
- Left ventricular (LV) MultiPoint™ pacing (MPP) enhances CRT response by engaging multiple LV sites.
- MPP can reduce device battery longevity due to increased pacing demands.
Purpose of the Study:
- To evaluate the impact of optimizing LV pacing configurations on battery longevity in MPP-enabled CRT devices.
- To assess the effectiveness of the LVCap™ Confirm algorithm in mitigating battery longevity reduction with MPP.
Main Methods:
- Retrospective analysis of patients from the MORE-CRT MPP trial with MPP-enabled CRT-D devices.
- Device interrogation to compare electrical characteristics and estimated battery longevities across different MPP settings.
- Comparison of battery longevity with MPP Off, MPP enabled with maximal cathode separation, and MPP enabled with optimized cathode configuration.
Main Results:
- Enabling MPP with maximal LV cathode separation reduced battery longevity by 15%.
- Optimizing LV pacing configurations by swapping LV1/LV2 cathodes to leverage LVCap™ Confirm reduced longevity reduction to 9%.
- A mean battery longevity improvement of 7.7% was achieved through simple LV1/LV2 cathode configuration adjustments.
Conclusions:
- Properly configuring LV pacing sites to utilize device-based capture management algorithms significantly reduces the impact of MPP on battery longevity.
- Simple adjustments in LV pacing configurations can optimize device performance and longevity in CRT-D systems.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
246
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Cardiomyopathy II: Dilated Cardiomyopathy
361
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361
Heart Failure VI: Adjunct Therapies
193
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
193
Pulse rhythm
1.2K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
297
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297


